Dentsply Sirona to Present at the 44th Annual J.P. Morgan Healthcare Conference
Dentsply Sirona (Nasdaq: XRAY) will present at the 44th Annual J.P.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Dentsply Sirona (Nasdaq: XRAY) will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on January 13, 2026 at 3:00 p.m. PT (6:00 p.m. ET).
Dan Scavilla, President and CEO, will discuss the company's Connected Dentistry portfolio, dental market trends, and progress on its return-to-growth strategy. A live audio webcast and replay will be available via the company's Investors website at https://investor.dentsplysirona.com.
Key Figures
- Conference date
- January 13, 2026
- J.P. Morgan Healthcare Conference presentation
- Presentation time PT
- 3:00 p.m. PT
- Scheduled conference presentation slot
- Presentation time ET
- 6:00 p.m. ET
- Scheduled conference presentation slot
Historical Context
-
Announced quarterly cash dividend of $0.16 per share with 2026 payment date.
-
Q3 2025 loss with impairment charges and revised FY25 guidance under Return-to-Growth plan.
-
Scheduled Q3 2025 investor call and webcast with supporting financial materials.
-
Appointed new Chief Commercial Officer to drive global sales and customer focus.
-
Decided to retain Wellspect Healthcare after strategic review, citing growth and cash flow.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CHARLOTTE, N.C., Jan. 06, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 13, 2026, at 3:00 p.m. PT (6:00 p.m. ET). During the presentation, Dan Scavilla, President and CEO of Dentsply Sirona, will provide an update on the Company's differentiated Connected Dentistry portfolio, dental market trends and the Company’s progress against its return-to-growth strategy.
Investors and other interested parties will be able to access a live audio webcast and audio webcast replay by visiting the Investors section of the Dentsply Sirona website at https://investor.dentsplysirona.com.
About Dentsply Sirona
Dentsply Sirona is the world’s largest diversified manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world-class brands. Dentsply Sirona’s innovative products provide high-quality, effective and connected solutions to advance patient care and deliver better and safer dental care. Dentsply Sirona’s headquarters is located in Charlotte, North Carolina. The Company’s shares are listed in the United States on Nasdaq under the symbol XRAY. Visit www.dentsplysirona.com for more information about Dentsply Sirona and its products.
Contact Information
Investors:
Wade Moody
Senior Manager, Investor Relations
InvestorRelations@dentsplysirona.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.